Integer Holdings (ITGR)
(Delayed Data from NYSE)
$132.43 USD
+3.19 (2.47%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $132.54 +0.11 (0.08%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$132.43 USD
+3.19 (2.47%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $132.54 +0.11 (0.08%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth C Momentum B VGM
Zacks News
Here's Why You Should Dump DENTSPLY (XRAY) Stock Right Now
by Zacks Equity Research
DENTSPLY (XRAY) incurs goodwill and intangible impairment charge. A lowered guidance is a concern.
Zacks.com highlights: Turtle Beach, Integer Holdings and PCM
by Zacks Equity Research
Zacks.com highlights: Turtle Beach, Integer Holdings and PCM
Here's Why You Should Hold on to Ecolab (ECL) Stock Now
by Zacks Equity Research
Ecolab (ECL) is likely to gain from a robust product portfolio, new product launches and expanding customer base.
Varian Acquires humediQ, Boosts Motion Management Portfolio
by Zacks Equity Research
Varian (VAR) incorporates humediQ's coveted IDENTIFY technology in its comprehensive suite of oncology solutions.
Allscripts Sunrise Picked by UK's Maidstone and Tunbridge Wells
by Zacks Equity Research
Allscripts' (MDRX) Sunrise platform witnesses a suite of developments, fortifying the company's global foothold.
OPKO Health (OPK) Earnings & Revenues Beat Estimates in Q2
by Zacks Equity Research
OPKO Health (OPK) gains from robust demand for its flagship RAYALDEE; declining segmental revenues raise concern.
Buy 3 Stocks With Rising Cash Flows to Scoop Up Big Gains
by Zacks Equity Research
Even though profit is a company's goal, cash is its lifeblood for existence and a measure of resiliency.
Allscripts Gains From Strong Results in Q2, Competition Rife
by Zacks Equity Research
Allscripts (MDRX) continues to gain from solid Q2 results and EHR developments; a competitive industry is a concern.
Inogen (INGN) Beats on Q2 Earnings, Lifts '18 Sales Guidance
by Zacks Equity Research
Inogen (INGN) puts up solid segmental show in Q2; international sales surge.
Zacks.com highlights: Turtle Beach, PetroChina, Harsco, Integer Holdings and Triton International
by Zacks Equity Research
Zacks.com highlights: Turtle Beach, PetroChina, Harsco, Integer Holdings and Triton International
5 Top Stocks With Striking Net Profit Margin
by Zacks Equity Research
Five stocks with handsome net profit margin that investors can count on for stellar returns.
Integer Holdings (ITGR) Beats on Q2 Earnings, '18 View Solid
by Zacks Equity Research
Integer Holdings (ITGR) gains on solid Cardio & Vascular revenues and high organic sales; a solid guidance raises optimism.
Hill-Rom (HRC) Q3 Earnings Top Estimates, Margins Expand
by Zacks Equity Research
Hill-Rom (HRC) registers a solid year-over-year revenue rise on strong domestic growth, driven by a robust performance at Patient Support Systems and Surgical Solutions.
ITGR vs. ABMD: Which Stock Is the Better Value Option?
by Zacks Equity Research
ITGR vs. ABMD: Which Stock Is the Better Value Option?
Zimmer Biomet (ZBH) Q2 Earnings Top Estimates, Margins Drop
by Zacks Equity Research
The improvement within Zimmer Biomet's (ZBH) global Knee and Hip sales performance and ongoing growth within the Asia Pacific region are encouraging.
GNC Holdings (GNC) Q2 Earnings Beat, Revenues Miss Mark
by Zacks Equity Research
Though GNC Holdings' (GNC) domestic retail comps are slightly weaker than expected, the company performs strongly in e-commerce business and at International segment.
Baxter (BAX) Q2 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Baxter (BAX) gains on the back of its core Renal Care segment in Q2; solid international sales encourage.
Zacks.com highlights: Hitachi, Integer Holdings, Panasonic and SunCoke Energy
by Zacks Equity Research
Zacks.com highlights: Hitachi, Integer Holdings, Panasonic and SunCoke Energy
Align Technology (ALGN) Beats on Earnings and Revenues in Q2
by Zacks Equity Research
Align Technology (ALGN) gains on solid contributions from Clear Aligner as well as Scanner and Service segments in Q2.
Chemed (CHE) Beats on Q2 Earnings & Revenues, View Raised
by Zacks Equity Research
Chemed (CHE) rides on strong contributions from the Roto-Rooter and VITAS businesses in Q2.
Stryker (SYK) Beats on Q2 Earnings, International Sales Up
by Zacks Equity Research
Stryker (SYK) gains from solid segmental performance in Q2.
Medidata (MDSO) Q2 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
Medidata (MDSO) gains from solid segmental performance in Q2; banks on strategic buyouts.
Boston Scientific (BSX) Beats on Q2 Earnings, Margins Down
by Zacks Equity Research
Boston Scientific (BSX) registers steady growth across all business lines and geographies in Q2.
Look Beyond Earnings: 4 Stocks With Increasing Cash Flows
by Zacks Equity Research
Cash is indispensable to any company. It gives strength and vitality to a company and is the key to its existence, development and success.
Zacks.com highlights: Integer Holdings, Stars Group, Turtle Beach, FTI Consulting, and Yatra Online
by Zacks Equity Research
Zacks.com highlights: Integer Holdings, Stars Group, Turtle Beach, FTI Consulting, and Yatra Online